San Diego – February 18, 2021 – Rady Children’s Institute for Genomic Medicine (RCIGM) is now licensed by New York State to perform clinical molecular testing making the Institute one of the few laboratories nationwide approved to perform whole exome and whole genome sequencing (WGS) on samples sent from all 50 states and the District of Columbia.
Findings of two new studies by Rady Children’s Institute for Genomic Medicine SAN DIEGO – Nov. 5, 2020— A vast majority of doctors and parents of babies in intensive care, with diseases of unknown origin, believe genomic sequencing is beneficial in managing care, according to two new papers published by Rady Children’s Institute for Genomic […]
ALISO VIEJO, Calif.; Oct. 14, 2020 – As gene-based diagnostics are shortening the path to an accurate diagnosis, the risk of disparities in service and support have increased. To reduce those disparities, Global Genes, a leading rare disease patient advocacy organization, is pleased to announce a new partnership with Rady Children’s Institute for Genomic Medicine […]
Mastermind Genomic Search Engine Now Part of RCIGM’s Analysis and Variant Interpretation Workflow Ann Arbor, Michigan – October 6, 2020 – The Rady Children’s Institute for Genomic Medicine (RCIGM) and Genomenon, Inc. today announced a strategic collaboration to accelerate the diagnosis of critically-ill newborns with rare genetic disorders. The collaboration combines the Institute’s genomic research […]
ORLANDO, Fla., and SAN DIEGO, Oct. 5, 2020 — AdventHealth for Children is partnering with Rady Children’s Institute for Genomic Medicine to bring rapid and ultra-rapid whole genome sequencing to Central Florida families for the first time. The testing will help critically ill babies and children in intensive care with unexplained medical conditions receive appropriate care.
State funded Medi-Cal pilot completed at 5 Children’s Hospitals Statewide In a pilot program funded by the State of California, Rady Children’s Hospital-San Diego demonstrated that a rapid precision medicine program for critically ill babies enrolled in Medi-Cal produced better health outcomes and reduced suffering for the infants while decreasing the cost of their care.
A consortium that includes many of San Diego’s top medical and scientific research institutes has launched a large-scale COVID-19 screening effort to better understand the spread and prevalence of the virus in the local community, with an initial focus on evaluating healthcare workers and first responders.
Innovative genetics solution pioneered by Rady Children’s Institute for Genomic Medicine; Eligible children are covered by parents’ health plan OAKLAND and SAN DIEGO, Calif. (March 9, 2020) – Blue Shield of California has become the first health plan in the United States to cover rapid and ultra-rapid Whole Genome Sequencing to help critically ill babies […]
Rady Children’s among founding members of innovative consortium SIOUX FALLS, S.D. — Nov. 5, 2019— Three more hospitals have signed on to rapidly integrate genetics and genomics into primary and specialty pediatric care through an innovative consortium with Sanford Health. Rady Children’s Hospital and Rady Children’s Institute for Genomic Medicine are founding members of the […]
Four-year National Institutes of Health Grant to Focus on Cardiomyopathy Research SAN DIEGO – Sept. 27, 2019 – The National Institutes of Health has awarded Rady Children’s Institute for Genomic Medicine (RCIGM) a four year, $3,049,054 grant to investigate how genetic interactions may influence cardiomyopathy (CM), a devastating heart disease that affects millions in the […]
© 2025 Rady Children's Institute for Genomic Medicine.